Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies

por Campbell, Robert, Chong, Geoffrey, Hawkes, Eliza A.
Publicado 2018

Treatment of metastatic colorectal cancer: focus on panitumumab

por Tay, Rebecca Y, Wong, Rachel, Hawkes, Eliza A
Publicado 2015

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma

por Martynchyk, Arina, Chowdhury, Rakin, Hawkes, Eliza A., Keane, Colm
Publicado 2023

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission

por Hawkes, Eliza A, Loh, Zoe, Estacio, Ortis, Chong, Geoff, Ha, Francis J, Gilbertson, Michael, Grigg, Andrew
Publicado 2018

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases

por Hawkes, Eliza A, Ladas, George, Cunningham, David, Nicholson, Andrew G, Wassilew, Katharina, Barbachano, Yolanda, Ratnayake, Gihan, Rao, Sheela, Chau, Ian
Publicado 2012

PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYM...

por Hawkes, Eliza A., Kim, Tae Min, Namuduri, Manjusha, Risal, Ashish, Shen, Biyi, Flink, Dina, Zhu, Min, Nolan, Siobhán, Brouwer-Visser, Jurriaan, Chaudhry, Aafia, Ambati, Srikanth, Mohamed, Hesham, Cho, Seok-Goo
Publicado 2023

P1230: T CELL CD62L EXPRESSION FOLLOWING NIVOLUMAB THERAPY IS ASSOCIATED WITH LONG TERM RESPONSE TO RITUXIMAB-NIVOLUMAB IN TREATMENT NAÏVE FOLLICULAR LYMPHOMA: RESULTS FROM THE 1ST...

por Koldej, Rachel, Barraclough, Allison, Ting Lee, Sze, Morgan, Huw, Holzwart, Nicholas, Koshy, Minu, Smith, Charmaine, Chong, Geoff, Gilbertson, Michael, Keane, Colm, Ting, Stephen, Churilov, Leonid, Ritchie, David, Hawkes, Eliza A.
Publicado 2023

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

por Tatarczuch, Maciej, Waltham, Mark, Shortt, Jake, Polekhina, Galina, Hawkes, Eliza A., Ho, Shir-Jing, Trotman, Judith, Brasacchio, Daniella, Co, Melannie, Li, Jessica, Ramakrishnan, Vanitha, Dunne, Karin, Opat, Stephen S., Gregory, Gareth P.
Publicado 2023

Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study

por Gates, Priscilla, Krishnasamy, Meinir, Wilson, Carlene, Hawkes, Eliza A., Doré, Vincent, Perchyonok, Yuliya, Rowe, Christopher C., Walker, Adam K., Vardy, Janette L., de Ruiter, Michiel B., Cushion, Tania, Dhillon, Haryana M., Gough, Karla
Publicado 2022

Pembrolizumab in relapsed or refractory Richter syndrome

por Armand, Philippe, Murawski, Niels, Molin, Daniel, Zain, Jasmine, Eichhorst, Barbara, Gulbas, Zafer, Hawkes, Eliza A., Pagel, John M., Phillips, Tycel, Ribrag, Vincent, Svoboda, Jakub, Stathis, Anastasios, Chatterjee, Arkendu, Orlowski, Robert, Marinello, Patricia, Christian, Beth
Publicado 2020

Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study

por Hawkes, Eliza A., Phillips, Tycel, Budde, Lihua Elizabeth, Santoro, Armando, Saba, Nakhle S., Roncolato, Fernando, Gregory, Gareth P., Verhoef, Gregor, Offner, Fritz, Quero, Cristina, Radford, John, Giannopoulos, Krzysztof, Stevens, Don, Thall, Aron, Huang, Bo, Laird, A. Douglas, Sandner, Robin, Ansell, Stephen M.
Publicado 2021

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

por Younes, Anas, Burke, John M., Cheson, Bruce D., Diefenbach, Catherine S., Ferrari, Silvia, Hahn, Uwe H., Hawkes, Eliza A., Khan, Cyrus, Lossos, Izidore S., Musuraca, Gerardo, Tani, Monica, Vitolo, Umberto, Yuen, Sam, Raval, Aparna, Shivhare, Mahesh, Nielsen, Tina G., Sellam, Gila, Sharman, Jeff P.
Publicado 2022

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REG...

por Shaw, Briony, Chung, Eliza, Wellard, Cameron, Yoo, Edward, Bennett, Rory, Birks, Callum, Johnston, Anna, Cheah, Chan, Hamad, Nada, Simpson, Jock, Barraclough, Allison, Ku, Matthew, Viiala, Nicholas, Ratnasingam, Sumita, Armytage, Tasman, Cochrane, Tara, Chong, Geoff, Lee, Denise, Manos, Kate, Keane, Colm, Wallwork, Stephanie, Opat, Stephen, Hawkes, Eliza A
Publicado 2023

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

por Opat, Stephen, Tedeschi, Alessandra, Hu, Bei, Linton, Kim M., McKay, Pamela, Leitch, Sophie, Coleman, Morton, Zinzani, Pier Luigi, Jin, Jie, Sun, Mingyuan, Sobieraj-Teague, Magdalena, Browett, Peter, Ke, Xiaoyan, Thieblemont, Catherine, Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Ho, Shir-Jing, Zhou, Keshu, Liang, Zhiyu, Xu, Jianfeng, Tankersley, Chris, Delarue, Richard, Co, Melannie, Trotman, Judith
Publicado 2023

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lym...

por Boyle, Stephen, Tobin, Joshua W. D., Perram, Jacinta, Hamad, Nada, Gullapalli, Veena, Barraclough, Allison, Singaraveloo, Lydia, Han, Min-Hi, Blennerhassett, Richard, Nelson, Niles, Johnston, Anna M., Talaulikar, Dipti, Karpe, Krishna, Bhattacharyya, Abir, Cheah, Chan Yoon, Subramoniapillai, Elango, Bokhari, Waqas, Lee, Cindy, Hawkes, Eliza A., Jabbour, Andrew, Strasser, Simone I., Chadban, Steven J., Brown, Christina, Mollee, Peter, Hapgood, Greg
Publicado 2021

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

por Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue, Begum, Ruwaida, Chau, Ian, Johnson, Peter, Ardeshna, Kirit M, Hawkes, Eliza A, Macheta, Marian P, Collins, Graham P, Radford, John, Forbes, Adam, Hart, Alistair, Montoto, Silvia, McKay, Pamela, Benstead, Kim, Morley, Nicholas, Kalakonda, Nagesh, Hasan, Yasmin, Turner, Deborah, Cunningham, David
Publicado 2018

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma

por Wong, Jonathan, Gruber, Emily, Maher, Belinda, Waltham, Mark, Sabouri-Thompson, Zahra, Jong, Ian, Luong, Quinton, Levy, Sidney, Kumar, Beena, Brasacchio, Daniella, Jia, Wendy, So, Joan, Skinner, Hugh, Lewis, Alexander, Hogg, Simon J., Vervoort, Stephin, DiCorleto, Carmen, Uhe, Micheleine, Gamgee, Jeanette, Opat, Stephen, Gregory, Gareth P., Polekhina, Galina, Reynolds, John, Hawkes, Eliza A., Kailainathan, Gajan, Gasiorowski, Robin, Kats, Lev M., Shortt, Jake
Publicado 2022

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance

por Barraclough, Allison, England, James T., Villa, Diego, Wight, Joel, Hapgood, Greg, Conn, Jason, Doo, Nicole Wong, Li, Eric Wenlong, Gilbertson, Michael, Shaw, Briony, Bishton, Mark J., Saeed, Malik, Ratnasingam, Sumita, Abeyakoon, Chathuri, Chong, Geoff, Wai, Shin Hnin, Ku, Matthew, Lee, Hui-Peng, Fleming, Kathryn, Tam, Constantine, Douglas, Genevieve, Cheah, Chan Y., Ng, Zi Yun, Rolfe, Tukten, Mills, Anthony K., Hamad, Nada, Cashman, Helen, Gleeson, Mary, Narayana, Manjunath, Hawkes, Eliza A.
Publicado 2023

The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma

por Opat, Stephen, Tedeschi, Alessandra, Linton, Kim, McKay, Pamela, Hu, Bei, Chan, Henry, Jin, Jie, Sobieraj-Teague, Magdalena, Zinzani, Pier Luigi, Coleman, Morton, Thieblemont, Catherine, Browett, Peter, Ke, Xiaoyan, Sun, Mingyuan, Marcus, Robert, Portell, Craig A., Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Mapp, Sally, Ho, Shir-Jing, Talaulikar, Dipti, Zhou, Ke-Shu, Co, Melannie, Li, Xiaotong, Zhou, Wenxiao, Cappellini, Massimo, Tankersley, Chris, Huang, Jane, Trotman, Judith
Publicado 2021